Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01143454 · ClinicalTrials.gov registry record

Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System

A clinical trial of Obesity and Atherosclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Recruiting
Registry status
5,000
Enrollment target
2
Study locations

NCT01143454: Recruiting study of Obesity and Atherosclerosis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT01143454 is a study of Obesity and Atherosclerosis that is actively recruiting participants, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,000 participants, above the 814-participant average among 1,053 other Obesity trials with a reported enrollment target (514% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01143454, a study of Obesity and Atherosclerosis, is actively recruiting participants, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

RECRUITING
Registry status
5,000 participants
Enrollment target
2
Study locations

Study Summary

Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected individuals may be asked to provide blood and other samples and may undergo tests to evaluate the heart, blood vessels and lung function. The testing is tailored to the individual and/or condition being studied. Nonaffected individuals may include relatives of affected individuals and healthy nonrelated volunteers. Objectives: \- To study individuals who have or are at risk for cardiovascular diseases, and in some cases their unaffected relatives and healthy volunteers. Eligibility: \- Individuals between 1 and 100 years of age. Participants may be healthy volunteers, individuals with cardiovascular diseases, or unaffected relatives of individuals with cardiovascular diseases. Design: * Participants will have some or all of the following tests, as directed by the study researchers: * Photography of the face and full body * Body measurements * Radiography, including chest or limb x-rays * Metabolic stress testing to study heart and muscle function * Echocardiography to study heart function * Magnetic resonance imaging (MRI) studies, including cardiovascular MRI, angiography, and contrast MRI, to study heart function and performance * Computed tomography (CT) angiogram to obtain images of the heart and lungs * Positron emission tomography (PET) imaging to study possible fat infiltration of the heart * Six-minute walk test to study heart, lung, and muscle function and performance * Vascular ultrasound to study blood vessel walls * Blood, tissue, and other specimens will be collected for research and testing, and will be taken either as part of the clinical study or during surgical procedures. * Follow-up studies may be performed under separate research protocols.

Primary Outcome

This protocol will allow condition-specific evaluation and sample collection to subjects with conditions associated with cardiovascular features and risk that may have long eluded diagnosis and to advance medical knowledge about rare and uncommon human diseases.

Interventions

  • DEVICE NSR IDE-MRI: Research pulse sequences

Study Locations (2)

Maryland

  • Suburban Hospital - Bethesda
  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2010-07-21

What NCT01143454 shows while recruiting

NCT01143454 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 814-participant average among 1,053 other Obesity trials with a reported enrollment target (514% higher).

The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which NSR IDE-MRI: Research pulse sequences is the first listed.

NCT01143454 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01143454 about?

NCT01143454 is a clinical study titled "Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System". Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at a high risk for heart diseases or diseases of their blood vessels. Depending on the condition being studied, both affected and nonaffected i...

What is the current status of trial NCT01143454?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2010-07-21.

What conditions does trial NCT01143454 study?

This clinical trial studies the following conditions: Obesity, Atherosclerosis, Metabolic Disease, Cardiomyopathy, Li-Fraumeni Syndrome.

What interventions are being tested in trial NCT01143454?

The interventions under investigation include: NSR IDE-MRI: Research pulse sequences (DEVICE).

Who is sponsoring clinical trial NCT01143454?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01143454 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01143454's enrollment target sits among peer trials

5,000 19th of 1053 higher than 1,032 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00060541 · 5,000 participants

    Evaluation and Treatment of Neurosurgical Disorders

  • NCT00575081 · 5,000 participants

    Physiological Brain Atlas Development

  • NCT00736749 · 5,000 participants

    Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

  • NCT00900198 · 5,000 participants

    Collection of Tissue Samples for Cancer Research

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01143454, the US trial registry maintained by the National Library of Medicine. NCT01143454 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.